Improved fibrinolytic capacity after withdrawal of steroid immunosuppression in renal transplant recipients. [electronic resource]
- Transplantation May 2000
- 2116-21 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0041-1337
10.1097/00007890-200005270-00026 doi
Adult Azathioprine--therapeutic use Biomarkers--blood Cyclosporine--therapeutic use Drug Therapy, Combination Female Fibrinolysis Humans Immunosuppressive Agents--adverse effects Kidney Transplantation--immunology Male Methylprednisolone--adverse effects Middle Aged Plasminogen Activator Inhibitor 1--blood Time Factors Tissue Plasminogen Activator--blood